Published on 20 Jun 2024 on Simply Wall St. · via Yahoo Finance

Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's...

Key Insights

AC Immune to hold its Annual General Meeting on 20th of JuneSalary of CHF578.0k is part of CEO Andrea Pfeifer's total remunerationTotal compensation is similar to the industry averageOver the past three years, AC Immune's EPS grew by 15% and over the past three years, the total loss to shareholders 46%

In the past three years, the share price of AC Immune SA (NASDAQ:ACIU) has struggled to grow and now shareholders are sitting on a loss. However, what is unusual is that EPS growth has been positive, suggesting that the share price has diverged from fundamentals. The AGM coming up on the 20th of June could be an opportunity for shareholders to bring these concerns to the board's attention. They could also influence management through voting on resolutions such as executive remuneration. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment.